1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Cebon, Jonathan S
Subject:  Antigens, Neoplasm.immunology

Results 1-10 of 10 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
118-Oct-2010Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.Wei, Joe; Waithman, Jason; Lata, Roleen; Mifsud, Nicole A; Cebon, Jonathan S ; Kay, Thomas; Smyth, Mark J; Sadler, Anthony J; Chen, Weisan
21-Jun-2010Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1.Cebon, Jonathan S ; Knights, Ashley J; Ebert, Lisa; Jackson, Heather M; Chen, Weisan
329-Apr-2010Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.Robson, Neil C; McAlpine, Tristan; Knights, Ashley J; Schnurr, Max; Shin, Amanda; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S 
41-Mar-2010Cancer vaccines: Where are we going?Cebon, Jonathan S 
517-Feb-2009Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.Gedye, Craig; Quirk, Juliet; Browning, Judy; Svobodová, Suzanne; John, Thomas ; Sluka, Pavel; Dunbar, P Rod; Corbeil, Denis; Cebon, Jonathan S ; Davis, Ian D
627-Jan-2009A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.Ebert, Lisa M; Liu, Yu Chih; Clements, Craig S; Robson, Neil C; Jackson, Heather M; Markby, Jessica L; Dimopoulos, Nektaria; Tan, Bee Shin; Luescher, Immanuel F; Davis, Ian D; Rossjohn, Jamie; Cebon, Jonathan S ; Purcell, Anthony W; Chen, Weisan
71-Jun-2006Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Nicholaou, Theo; Ebert, Lisa; Davis, Ian D; Robson, Neil; Klein, Oliver ; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S 
823-Sep-2004The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.Shackleton, Mark; Davis, Ian D; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin; Chen, Qiyuan; Parente, Phillip; Jefford, Michael; Masterman, Kelly-Anne; Caron, Dania; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S 
914-Jun-2004Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.Chen, Qiyuan; Jackson, Heather M; Parente, Phillip; Luke, Tina; Rizkalla, Mark; Tai, Tsin Yee; Zhu, He-Cheng; Mifsud, Nicole A; Dimopoulos, Nektaria; Masterman, Kelly-Anne; Hopkins, Wendie; Goldie, Heather; Maraskovsky, Eugene; Green, Simon; Miloradovic, Lena; McCluskey, James; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
101-May-1997Clinical promise of tumour immunology.Scott, Andrew M ; Cebon, Jonathan S